4//SEC Filing
WYETH 4
Accession 0001209191-09-049107
CIK 0000005187operating
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 5:24 PM ET
Size
30.4 KB
Accession
0001209191-09-049107
Insider Transaction Report
Form 4
WYETHWYE
POLAN MARY LAKE PH D
Director
Transactions
- Disposition to Issuer
Non-Employee Director Stock Option
2009-10-15−3,000→ 0 totalExercise: $56.59→ Common Stock (3,000 underlying) - Disposition to Issuer
Non-Employee Director Stock Option
2009-10-15−4,000→ 0 totalExercise: $60.70→ Common Stock (4,000 underlying) - Disposition to Issuer
Non-Employee Director Stock Option
2009-10-15$9.36/sh−4,000$37,440→ 0 totalExercise: $40.22→ Common Stock (4,000 underlying) - Disposition to Issuer
Non-Employee Director Stock Option
2009-10-15$1.36/sh−3,500$4,760→ 0 totalExercise: $48.22→ Common Stock (3,500 underlying) - Disposition to Issuer
Phantom Stock Units
2009-10-15$49.58/sh−3,520.89$174,566→ 0 total→ Common Stock (3,520.89 underlying) - Disposition to Issuer
Common Stock (Restricted Stock Trust)
2009-10-15$49.58/sh−13,544.643$671,543→ 0 total(indirect: By Trust) - Disposition to Issuer
Non-Employee Director Stock Option
2009-10-15−4,000→ 0 totalExercise: $56.52→ Common Stock (4,000 underlying) - Disposition to Issuer
Non-Employee Director Stock Option
2009-10-15$8.53/sh−4,000$34,120→ 0 totalExercise: $41.05→ Common Stock (4,000 underlying) - Disposition to Issuer
Non-Employee Director Stock Option
2009-10-15$6.01/sh−4,000$24,040→ 0 totalExercise: $43.57→ Common Stock (4,000 underlying) - Disposition to Issuer
Non-Employee Director Stock Option
2009-10-15−3,500→ 0 totalExercise: $56.00→ Common Stock (3,500 underlying) - Disposition to Issuer
Common Stock
2009-10-15−847→ 0 total - Disposition to Issuer
Phantom Stock Units (Retirement)
2009-10-15$49.58/sh−17,064.586$846,062→ 0 total→ Common Stock (17,064.586 underlying)
Footnotes (4)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Wyeth, Pfizer Inc. and Wagner Acquisition Corp. dated as of January 25, 2009 (as amended, the "Merger Agreement"), each of these shares was cancelled at the effective time of the merger and converted into the right to receive $33.00 in cash and 0.985 of a share of Pfizer Inc. common stock.
- [F2]Pursuant to the Merger Agreement, each of these shares was cancelled at the effective time of the merger in exchange for cash equal to the per share value of the merger consideration of $49.58.
- [F3]Pursuant to the Merger Agreement, each outstanding and unexercised option, whether vested or unvested, was cancelled at the effective time of the merger in exchange for cash equal to the product of (a) the number of shares underlying such option and (b) the excess, if any, of the per share value of the merger consideration of $49.58 over the per share exercise price of the option.
- [F4]Pursuant to the Merger Agreement, all phantom stock units, each of which represents the value of one actual share of common stock and has no exercise feature or expiration date, was cancelled at the effective time of the merger in exchange for cash equal to the product of (a) the number of shares underlying the phantom stock units and (b) the per share value of the merger consideration of $49.58.
Documents
Issuer
WYETH
CIK 0000005187
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000005187
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 5:24 PM ET
- Size
- 30.4 KB